Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Comparing Twice vs Thrice Weekly Hemodialysis for Elderly Patients

Official title: A Pragmatic Randomized Clinical Trial: Twice-weekly vs Thrice-weekly Incident hemoDialysis in Elderly Patients

Run by Soonchunhyang University Hospital · NCT06141798 · Data updated 2026-11-12

This study tests whether doing hemodialysis twice a week instead of three times can help elderly patients with kidney disease feel better and stay out of the hospital.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment428 (estimated)
SponsorSoonchunhyang University Hospital
Academic / other
Locations7 sites (Bucheon-si and 6 other locations)
StatusRecruiting
StartedNovember 23, 2021
Main results expectedMay 9, 2026
Study endsMay 31, 2026
Registry record updatedMay 11, 2026
Trial IDNCT06141798 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are elderly patients aged 60 years and older who are starting maintenance hemodialysis and have some residual renal function.

Probably not a fit

Patients with severe cardiac issues, liver cirrhosis, active malignancies, or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of initiating hemodialysis treatment twice weekly versus the standard thrice weekly regimen in elderly patients with end-stage kidney disease (ESKD). The study aims to assess whether a less frequent dialysis schedule can reduce hospitalization rates and improve quality of life for frail elderly patients who may have multiple comorbidities. By focusing on patients with residual renal function, the trial seeks to validate a potentially safer and more effective approach to renal replacement therapy in this vulnerable population.

Why it matters

Potential benefit: If successful, this study could lead to improved health outcomes and quality of life for elderly patients undergoing hemodialysis.

How similar studies have gone: While the approach of less frequent hemodialysis is being explored, this specific comparison in elderly patients is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥60 years
* Clinical diagnosis of end stage kidney disease
* Starting maintenance hemodialysis within one month
* 24-hour urine output ≥ 500 ml at randomization
* Sufficient understanding of the study procedures and requirements.

Exclusion Criteria:

* Left ventricular ejection fraction \< 40%)
* Liver cirrhosis
* Current treatment for an active malignancy or active infection
* Onability or refusal to provide written informed consent
* enrollment in another clinical trial.

Where it's running

  • Soonchunhyang University Hospital Bucheon
    Bucheon-si, South Korea
    Recruiting
  • Hallym University Medical Center- Chuncheon
    Chuncheon, South Korea
    Completed
  • Soonchunhyang University Seoul Hospital
    Seoul, South Korea
    Active not recruiting
  • Kangbuk Samsung Medical Center
    Seoul, South Korea
    Completed
  • Koera University Guro Hospital
    Seoul, South Korea
    Completed
  • The Catholic University of Korea, Yeouido St. Mary's Hospital
    Seoul, South Korea
    Completed
Show 1 more location
  • Yonsei University, Wonju Severance Christian Hospital
    Wŏnju, South Korea
    Completed

Study contacts

  • Principal investigator: Soon Hyo Kwon, MD — Soonchunhyang University Hospital
  • Study coordinator: Soon Hyo Kwon, MD
  • Email: ksoonhyo@schmc.ac.kr
  • Phone: +8227099177

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.